Prognosis and Treatment of Atrial Fibrillation Patients by European Cardiologists: One Year Follow-Up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot Registry)

Study Questions:

What are the symptoms, use of antithrombotic therapy, and rate versus rhythm strategies, as well as determinants of mortality and/or stroke/transient ischemic attack (TIA)/peripheral embolism during 1-year follow-up in a contemporary European registry of atrial fibrillation (AF) patients?